Ameriprise’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125M Buy
257,702
+67,082
+35% +$17.8M 0.03% 520
2026
Q1
$20.9M Sell
190,620
-28,087
-13% -$4M ﹤0.01% 1376
2025
Q4
$38M Buy
218,707
+32,965
+18% +$5.51M 0.01% 1031
2025
Q3
$40.3M Sell
185,742
-925,202
-83% -$152M 0.01% 1013
2025
Q2
$100M Buy
1,110,944
+658,161
+145% +$52M 0.02% 550
2025
Q1
$33M Sell
452,783
-432,373
-49% -$40M 0.01% 1037
2024
Q4
$117M Sell
885,156
-101,505
-10% -$9.53M 0.03% 492
2024
Q3
$51.7M Buy
986,661
+975,506
+8,745% +$45.8M 0.01% 832
2024
Q2
$675K Sell
11,155
-54,816
-83% -$3.8M ﹤0.01% 3332
2024
Q1
$4.89M Buy
+65,971
New +$4.89M ﹤0.01% 2388

Other funds holding ALAB

Ameriprise's ALAB Position: Q2 2026 in Review

Ameriprise increased its Astera Labs (ALAB) stake by 35% in Q2 2026, buying an estimated $17.8M and bringing the position to 257,702 shares worth $125M. The position accounts for 0.03% of the portfolio, ranked #520.

Ameriprise first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Ameriprise held 257,702 shares of Astera Labs worth $125M as of Q2 2026.
  • Ameriprise bought 67,082 Astera Labs shares in Q2 2026, an estimated $17.8M.
  • Astera Labs made up 0.03% of Ameriprise's portfolio in Q2 2026, its #520 holding.
  • Ameriprise first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.